Literature DB >> 12963381

When should old therapies be abandoned? A modern look at old studies on topical ampicillin.

Charalambos P Charalambous1, Charalambos Charalambous, Marios Tryfonidis, Rick Swindell, A Pamela Lipsett.   

Abstract

OBJECTIVE: We sought to determine whether topical ampicillin can reduce the rate of wound infections in clean contaminated surgical wounds (appendectomy, colorectal surgery).
METHOD: All randomized controlled trials examining the use of topical ampicillin in appendectomy and colorectal surgery published in English were identified via a Medline, Advanced Medline, and Cochraine Controlled Trials Register search and a meta-analysis performed.Results. Topical ampicillin vs. no antibiotic prophylaxis in clean contaminated wounds significantly reduced surgical wound infection rates (Odds Ratio (OR)=0.084, 95% CI, 0.04-0.16, P<0.0001). Topical ampicillin vs. no antibiotic prophylaxis in contaminated wounds also reduced surgical wound infection (OR=0.262, 95% CI, 0.14-0.51, P<0.0001). Topical ampicillin combined with systemic antibiotics vs. systemic antibiotics alone did not reduce surgical wound infection rate (OR=0.927, 95% CI, 0.27-1.72, P=0.90).
CONCLUSION: Topical ampicillin significantly reduces the rate of surgical wound infections in clean contaminated surgery. A significant but smaller effect is seen in appendectomies where the appendix is gangrenous or perforated. Topical ampicillin did not confer any additional benefit when systemic antibiotics are used. While ampicillin may no longer be an effective agent, topical application of antibiotics is effective.Summary. A meta-analysis of studies using topical ampicillin for the prevention of infection in clean contaminated wound suggests that topical ampicillin is effective, but no incremental benefit is seen with systemic antibiotics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12963381     DOI: 10.1016/s0163-4453(03)00071-9

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  7 in total

Review 1.  Factors influencing antibiotic prophylaxis for surgical site infection prevention in general surgery: a review of the literature.

Authors:  Anna R Gagliardi; Darlene Fenech; Cagla Eskicioglu; Avery B Nathens; Robin McLeod
Journal:  Can J Surg       Date:  2009-12       Impact factor: 2.089

Review 2.  Intra-operative wound irrigation to reduce surgical site infections after abdominal surgery: a systematic review and meta-analysis.

Authors:  Tara C Mueller; Martin Loos; Bernhard Haller; André L Mihaljevic; Ulrich Nitsche; Dirk Wilhelm; Helmut Friess; Jörg Kleeff; Franz G Bader
Journal:  Langenbecks Arch Surg       Date:  2015-02-14       Impact factor: 3.445

Review 3.  Treating Wisely: The Surgeon's Role in Antibiotic Stewardship.

Authors:  Ira L Leeds; Anne Fabrizio; Sara E Cosgrove; Elizabeth C Wick
Journal:  Ann Surg       Date:  2017-05       Impact factor: 12.969

4.  Topical antimicrobial prophylaxis in colorectal surgery for the prevention of surgical wound infection: a systematic review and meta-analysis.

Authors:  R L Nelson; N M Iqbal; A Kravets; R Khateeb; M Raza; M Siddiqui; I Taha; A Tummala; R Epple; S Huang; M Wen
Journal:  Tech Coloproctol       Date:  2018-07-17       Impact factor: 3.781

Review 5.  Topical antibiotics for preventing surgical site infection in wounds healing by primary intention.

Authors:  Clare F Heal; Jennifer L Banks; Phoebe D Lepper; Evangelos Kontopantelis; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2016-11-07

6.  Oral metronidazole as antibiotic prophylaxis for patients with nonperforated appendicitis.

Authors:  Hassan Ravari; Ali Jangjoo; Jalal Motamedifar; Kasra Moazzami
Journal:  Clin Exp Gastroenterol       Date:  2011-12-07

7.  Risk of surgical site infection and efficacy of antibiotic prophylaxis: a cohort study of appendectomy patients in Thailand.

Authors:  Nongyao Kasatpibal; Mette Nørgaard; Henrik Toft Sørensen; Henrik Carl Schønheyder; Silom Jamulitrat; Virasakdi Chongsuvivatwong
Journal:  BMC Infect Dis       Date:  2006-07-12       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.